Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC)

Historical Holders from Q2 2021 to Q3 2025

Symbol
IPSC on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
86,307,537
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
20,280,322
Holdings value
$10,103,490
% of all portfolios
0%
Number of holders
53
Number of buys
13
Number of sells
-40
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Venrock Healthcare Capital Partners III, L.P. 4.7% $2,097,309 3,957,186 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
Bain Capital Life Sciences Opportunities III, LP 4.1% $1,762,227 3,538,609 Bain Capital Life Sciences Opportunities III, LP 30 Sep 2025
Casdin Capital, LLC 3.7% $1,702,527 3,212,316 Casdin Capital, LLC 31 Mar 2025

Institutional Holders of Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 20,280,322 $10,103,490 -$1,196,912 $0.498 53
2025 Q2 22,628,192 $12,642,486 -$3,582,180 $0.5587 64
2025 Q1 29,565,044 $14,071,235 -$4,277,613 $0.476 69
2024 Q4 36,396,514 $36,761,199 -$7,768,598 $1.01 70
2024 Q3 39,649,193 $67,797,499 -$1,211,276 $1.71 66
2024 Q2 40,117,934 $102,301,880 +$40,961,743 $2.55 59
2024 Q1 23,113,173 $96,605,177 +$22,882,584 $4.18 66
2023 Q4 17,675,436 $58,683,678 -$543,594 $3.32 60
2023 Q3 18,060,757 $36,118,983 -$2,770,150 $2 53
2023 Q2 19,290,007 $60,957,915 -$2,350,461 $3.16 62
2023 Q1 20,016,851 $69,456,630 -$4,620,580 $3.47 63
2022 Q4 20,893,156 $107,178,277 -$3,631,215 $5.13 65
2022 Q3 21,098,040 $208,661,435 -$4,940,964 $9.89 52
2022 Q2 21,756,667 $182,752,181 -$3,241,178 $8.4 51
2022 Q1 22,151,698 $278,859,136 +$11,504,710 $12.59 51
2021 Q4 21,137,514 $335,200,000 +$24,348,825 $15.86 50
2021 Q3 19,798,633 $496,205,288 +$62,122,502 $25.16 47
2021 Q2 16,881,896 $490,834,435 +$490,834,432 $29.34 35